河北圣雪大成制药有限责任公司
Hebei Shengxue Dacheng Pharmaceutical Co. Ltd.
Country: CN CDE+DMF+CEP VERY_HIGH
🇨🇳 CDE
5
5 products shown
🇺🇸 DMF
2
2 products shown
🇪🇺 CEP
11
13 products shown
Total
18
registrations
🇨🇳 CDE 注册 (5)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Colistimethate Sodium TQA3729 | 8068-28-8 | Class A | Y20240000314 |
| Oxytetracycline 土霉素 | 79-57-2 | Class A | Y20190003133 |
| Oxytetracycline Hydrochloride 盐酸土霉素 | 79-57-2 | Class A | Y20190003105 |
| Polymyxin B 硫酸多黏菌素B | - | Class A | Y20240000964 |
| Streptomycin 硫酸链霉素 | 57-92-1 | Class A | Y20190002421 |
🇺🇸 DMF 注册 (2)
| Product | CAS | DMF Number | Date |
|---|---|---|---|
| Colistimethate Sodium TQA3729 | 8068-28-8 | 35177 | 2020-09-22 |
| Polymyxin B Sulfate 硫酸多黏菌素B（供局部用） | 1405-20-5 | 42636 | 2025-09-24 |
🇪🇺 CEP 注册 (13)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Colistimethate Sodium, Sterile 多黏菌素E甲磺酸钠 | 8068-28-8 | CEP 2019-246 - Rev 02 | 2024-04-12 |
| Colistin Sulfate 硫酸黏菌素 | 1066-17-7 | R1-CEP 2009-144 - Rev 01 | 2019-02-21 |
| Dihydrostreptomycin Sulfate For Veterinary Use, Sterile | 5490-27-7 | CEP 2018-146 - Rev 03 | 2024-09-02 |
| Oxytetracycline Dihydrate 土霉素 | 6153-64-6 | CEP 2004-055 - Rev 03 | 2024-10-09 |
| Oxytetracycline Dihydrate 土霉素 | 6153-64-6 | R0-CEP 2021-031 - Rev 00 | 2022-06-23 |
| Oxytetracycline Dihydrate, Process B | 6153-64-6 | CEP 2017-258 - Rev 01 | 2024-05-22 |
| Oxytetracycline Hydrochloride 盐酸土霉素 | 79-57-2 | CEP 2021-099 - Rev 02 | 2026-01-20 |
| Oxytetracycline Hydrochloride 盐酸土霉素 | 79-57-2 | R0-CEP 2009-145 - Rev 00 | 2010-09-08 |
| Oxytetracycline Hydrochloride, Process B - Micronised, Non-micronised 盐酸土霉素 | 2058-46-0 | R1-CEP 2013-090 - Rev 02 | 2021-09-09 |
| Polymyxin B Sulfate 硫酸多黏菌素B（供局部用） | 1405-20-5 | CEP 2024-389 - Rev 00 | 2025-09-03 |
| Spectinomycin Dihydrochloride Pentahydrate 大观霉素 | 22189-32-8 | CEP 2018-152 - Rev 01 | 2024-10-30 |
| Spectinomycin Sulfate Tetrahydrate For Veterinary Use 大观霉素 | 64058-48-6 | CEP 2020-069 - Rev 02 | 2025-09-18 |
| Streptomycin Sulfate 硫酸链霉素 | 3810-74-0 | R1-CEP 2004-052 - Rev 03 | 2026-04-10 |
Source: cde+fda_direct; DMF高置信 | Updated: 2026-09-12 06:00:12